Company Profile
Xtant Medical Stock Price, News & Analysis
Company overview
Business overview
Xtant Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on 美国证券交易所, Xtant Medical is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Xtant Medical makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Xtant Medical trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
XTNT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Xtant Medical’s catalysts are orthopedic biologics, spine product execution, and any margin or portfolio update that improves the business mix. The market cares about steady adoption rather than a single headline.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
Source: Xtant Medical
- 02
Xtant Medical Reports Third Quarter 2025 Financial Results
Source: Xtant Medical
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.